Find the latest pharmaceutical market place for formulations enquiry about Olmesartan Medoxomil on PharmaCompass.com.

In-licensing of Various FDFs needed in Spain [ENA14014]

A specialty pharmaceutical company based in Canada that focuses in generic product development and regulatory services is looking for suppliers of In-licencing & Marketing Authorization of Various FDFs with supplies in bulk quantity for the European market. The suppliers must support this enquiry with Dossier.
1. Amlodipine Besylate (5 mg/ 5 mg/ 10 mg/ 10 mg) + Indapamide (1.25 mg/ 1.25 mg/ 2.5 mg/ 2.5 mg) + Perindopril Arginine (5 mg/ 10 mg/ 5 mg/ 10 mg) Film-coated Tablets
2. Amlodipine Besylate (50 mg/ 5 mg/ 10 mg) + Valsartan (80 mg/ 160 mg/ 160 mg) Film-coated Tablets
3. Candesartan Cilexetil (8 mg/ 16 mg/ 32 mg/ 32 mg) + Hydrochlorothiazide (12.5 mg/ 12.5 mg/ 12.5 mg/ 25mg) Tablets
4. Amlodipine Besylate (5 mg/ 10 mg/ 5 mg/ 10 mg/ 5 mg) + Hydrochlorothiazide (160 mg/ 160 mg/ 160 mg/ 160 mg/ 320 mg) + Valsartan (12.5mg/ 12.5 mg/ 25 mg/ 25 mg/ 25 mg) Film-coated Tablets
5. Amlodipine Besylate (20 mg/ 40 mg/ 40 mg/ 7 mg/ 40 mg) + Hydrochlorothiazide (5 mg/ 5 mg/ 10 mg/ 25 mg/ 25 mg) + Olmesartan Medoxomil (12.5 mg/ 12.5 mg/ 12.5 mg/ 25 mg/ 25mg) Film-coated Tablets
6. Ramipril (2.5 mg/ 5 mg/ 5 mg) + Hydrochlorothiazide (12.5 mg/ 25 mg/ 12.5 mg) Tablets
7. Candesartan Cilexetil (2 mg, 4 mg, 8 mg, 16 mg & 32 mg) Tablets

Reply

18 Jun 2022

saudiarabiapng-1555324364png-1605701218 Flag

Various Finished Dosage Formulations needed in United Arab Emirates [ENA12926]

A leading pharmaceutical company that deals in the manufacturing & distribution of generic pharmaceutical products in almost all lifestyle disease segments, including cardiovascular, anti-ulcerant, anti-diabetics, anti-arthritis, NSAIDs, respiratory, anti-histamine formulations, anti-infectives is looking for suppliers of Various Finished Dosage Formulations in bulk quantity. The suppliers must support this enquiry with eCTD Dossier & CPP from a regulated market.
1. Diclofenac Potassium (50 mg) Powder for Solution (Oral)
2. Vildagliptin (50 mg) Tablets
3. Vildagliptin (50 mg) + Metformin (500 mg) Tablets
4. Vildagliptin (50 mg) + Metformin (850 mg) Tablets
5. Vildagliptin (50 mg) + Metformin (1000 mg) Tablets
6. Olmesartan Medoxomil (10 mg, 20 mg & 40 mg) Tablets
7. Olmesartan (20 mg) + Hydrochlorothiazide (12.5 mg) Tablets
8. Olmesartan (20 mg) + Amlodipine (5 mg) Tablets
9. Olmesartan (20 mg) + Amlodipine (10 mg) Tablets
10. Olmesartan (40 mg) + Amlodipine (5 mg) Tablets
11. Olmesartan (40 mg) + Amlodipine (10 mg) Tablets
12. Esomeprazole (20 mg) + Naproxen (375 mg) Modified-release Tablets
13. Esomeprazole (20 mg) + Naproxen (500 mg) Modified-release Tablets

Reply

08 Mar 2022

Various Finished Dosage Formulations required with CTD Dossiers needed in Ukraine [ENA07186]

A pharmaceutical manufacturing company that deals in portfolios like antibiotics, antitussive, painkillers, anti-anemic & many more is looking for suppliers of Various Finished Dosage Formulations. The end market are CIS countries (Kazakhistan, Azerbaijan, Uzbekistan & Ukraine). The suppliers must support this enquiry with CPP.
1. Ademetionine 400 mg Tablet (10,000 units in 20 pack size)
2. Candesartan + Amlodipine + HCTZ (16 mg + 5 mg + 12.5 mg and 16 mg + 10 mg + 12.5 mg) Tablet (20,000 units in 28 pack size for each)
3. Finasteride 5 mg + Tadalafil 5 mg Tablet (10,000 units in 28 pack size)
4. Olmesartan + Amlodipine + HCTZ (20 mg + 5 mg + 12.5 mg and 40 mg + 5 mg + 12.5 mg) Tablet (20,000 units in 28 pack size for each)
5. Solifenacin 6 mg + Tamsolusin 0.4 mg Tablet (20,000 units in 30 pack size)
6. Rivaroxaban 2.5 mg, 10 mg, 15, mg, 20 mg Tablet

Reply

29 Apr 2020

Enquiry// Various finished formulations needed in Kenya [ENA00928]

Taurus Medical is looking for Pharmacy & Poisons Board (PPB) approved manufacturer or suppliers for below listed products:
1. Ferrous ascorbate 30 mg + Folic acid 0.5 mg syrup
2. Multivitamin Syrup (Centrum combination)
3. Losartan 50 mg + Hydrochlorothiazide 12.5 mg tablets
4. Nebivolol tablets
5. Enalapril 2.5 mg, 5 mg & 10 mg tablets
6. Amlodipine 5 & 10 mg tablets
7. Sitagliptin 50 mg+ Metformin 500 mg tablets
8. Vildagliptin 50 mg + Metformin 500 mg tablets
9. Olmesartan tablets
10. Hydrochlorothiazide 25 mg & 50 mg
11. Esomeprazole 40 mg tablets
12. Amoxyclav 157 mg & 228 mg suspension
13. Amoxyclav 375 mg, 625 mg & 1 g Tablets
14. Amoxycillin 500 mg capsules
15. Amoxycillin 125 mg/5 ml & 250 mg/5 ml dry suspension
16. Flucloxacillin 500 mg capsules
17. Flucloxacillin 125 mg/5 ml suspension
18. Levofloxacin 750 mg tablets
19. Etoricoxib 60 mg, 90 mg & 120 mg
20. Linezolid 600 mg
21. Amoxy 250 DT tablets
22. Methylcobalamine + Gabapentin tablets
23. Aceclofenac 100 mg & 200 mg SR tablets
24. Esomeprazole 20 + Clarithromycin 500 + Amoxy 1000 mg
25. Pantoprazole 20 + Clarithromycin 500 + Amoxy 1000 mg
26. Azithromycin 200 mg/5 ml dry suspension
27. Azithromycin 500 mg + Secnidazole 1 g + Fluconazole 150 capsules
28. Losartan 100 mg + Hydrochlorothiazide 25 mg tablets
Interested suppliers should contact Sanjeev Dagar via Email: taurus.epz@gmail.com or Tel: +254789843746.

Reply

21 May 2018

Enquiry// Looking for Marketing Partners for various Finished Dose Formulations in China [ENA00365]

Inventia Healthcare, one of the leading drug delivery companies in India is searching for partners for its US FILED Products for the Chinese Market:

Products developed against international innovator:
1. Gliclazide 30/60 mg ER Tablets
2. Metformin HCl 500/750/1000 mg SR Tablets.
3. Lansoprazole 15/30 mg EC Capsules
4. Metoprolol 25/50/100/200 mg ER Tablets
5. Olmesartan Medoxomil 5/20/40 mg Tablets
6. Telmisartan 20/40/80 mg Tablets
7. Telmisartan + Hydrochlorthiazide 40/12.5, 80/12.5, 80/25 mg Tablets
8. Duloxetine 20/30/60 mg DR Capsules
9. Venlafaxine 37.5/75/150 mg SR Capsules
10. Darifenacin Hydrobromide 7.5/15 mg ER Tablets
11. Felodipine 2.5/5/10 mg ER Tablets
12. Rosuvastatin 5 /10/20/40 mg Tablets
13. Iloperidone 1/2/4/6/8/10/12 mg Tablets
14. Paliperidone 1.5/3/6/9 mg ER Tablets
15. Tolterodine Tartrate 2/4 mg ER Capsules

New Products Under development
1. Sitagliptin + Metformin 50/500 mg, 50/1000 mg Tablets
2. Sitagliptin + Metformin ER 50/500 mg, 50/1000; 100/1000 mg Tablets
3. Dapagliflozin 5/10 mg Tablets
4. Mesalamine 1.2 mg DR Tablets
5. Ezetimibe 10 mg Tablets
Interested partners can contact Sumeet Mehta at sumeet.mehta@inventiahealthcare.com or call +91-9930922062.

Reply

12 Jun 2017

Enquiry// Looking for Marketing Partners for various Finished Dose Formulations across Emerging Markets [ENA00236...

Inventia Healthcare, is searching for partners for:
DEVELOPED PRODUCTS
South East Asia, CIS, Australia, Middle East & Africa, LATAM:-
1. Lansoprazole 15/30 mg EC Capsules
2. Metoprolol 25/50/100/200 mg ER Tablets
3. Olmesartan Medoxomil 5, 20, 40 mg Tablets
4. Telmisartan 20/40/80 mg Tablets
5. Telmisartan + Hydrochlorthiazide 40/12.5, 80/12.5, 80/25 mg Tablets
6. Duloxetine 20/30/60 mg DR Capsules
7. Venlafaxine 37.5/75/150 mg SR Capsules
8. Darifenacin Hydrobromide 7.5/15 mg ER Tablets

South East Asia, CIS, Australia, Middle East & Africa, LATAM Argentina, Uruguay, Paraguay, Chile:-
1. Metformin HCl 750 mg SR Tablets

South East Asia, CIS, Australia, Middle East & Africa, LATAM, India:-
1. Gliclazide 30/60 mg ER Tablets
2. Felodipine 2.5/5/10 mg ER Tablets
3. Rosuvastatin 5 /10 /20/40 mg Tablets

Dossier for South East Asia, CIS, Australia Korea, Taiwan, China, Russia, Ukraine, Kazakhstan, Uzbekistan, Hong Kong, Thailand, Middle East & Africa, South Africa, GCC, Iraq, Algeria, LATAM, Argentina, Uruguay, Paraguay, Chile, India:-
1. Metformin HCl 500 mg SR Tablets

Dossier for South East Asia, CIS, Australia, Korea, Taiwan, China, Russia, Ukraine, Kazakhstan, Uzbekistan, Hong Kong, Thailand, Malaysia, LATAM, Argentina, Uruguay, Paraguay, Chile, All countries in SEA, CIS, Australia, Middle East & Africa:-
1. Metformin HCl 1000 mg SR Tablets
Interested partners can contact @ https://www.pharmacompass.com/api-manufacturers/inventia-healthcare-private-limited

Reply

02 Mar 2017

Enquiry// Approved/Ready to file dossiers for Capecitabine, Olmesartan and Olmesartan + Hydrochlorothiazide neede...

Babaria IP, a professionally managed premier law firm is searching for Approved/Ready to file dossiers for Capecitabine, Olmesartan and Olmesartan + Hydrochlorothiazide for one of their clients. Interested suppliers can contact Ketana Babaria via Email: b_ketana@babariaip.com or via Tel: +91-9825045620.

Reply

22 Feb 2017